Results 51 to 60 of about 1,744 (184)

Treatment of gram - positive infections in critically ill patients [PDF]

open access: yes, 2014
Gram-positive bacteria to include methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), and enterococci, to include vancomycin-resistant enterococci (VRE), display a remarkable array of resistance and ...
Cristina Vazquez-Guillamet   +1 more
core   +2 more sources

Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 18, Issue 12, Page 1417-1424, December 2020., 2020
Summary Background and objectives Erysipelas, caused by beta‐hemolytic streptococci, and limited cellulitis, frequently caused by Staphylococcus aureus or other bacteria, are skin and soft tissue infections characterized by typical clinical signs. However, despite the therapeutical relevance they are often not differentiated (e.g in clinical trials ...
Christian Drerup   +3 more
wiley   +1 more source

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

open access: yesGMS Infectious Diseases, 2019
Complicated infections such as osteomyelitis, skin and soft tissue infections or endocarditis often require antibiotic therapies that can last up to several weeks. The prolonged hospital length of stay (LOS) leads to a dramatic increase in costs.
Wilke, Michael   +5 more
doaj   +1 more source

Diagnostischer Wert von Laborparametern zur Unterscheidung zwischen Erysipel und begrenzter Phlegmone

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 18, Issue 12, Page 1417-1425, December 2020., 2020
Zusammenfassung Hintergrund und Ziele Das Erysipel, hervorgerufen durch beta‐hämolysierende Streptokokken, und die begrenzte Phlegmone, häufig ausgelöst durch Staphylococcus aureus oder andere Bakterien, sind Infektionen der Haut und des Weichteilgewebes mit typischen klinischen Symptomen. Allerdings wird oft (etwa in klinischen Studien) nicht zwischen
Christian Drerup   +3 more
wiley   +1 more source

Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.

open access: yesPLoS ONE, 2021
BackgroundOritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI).
Kimberly Saddler   +8 more
doaj   +1 more source

Evaluation of prognostic value of MEDS, MEWS, and CURB‐65 criteria and sepsis I and sepsis III criteria in patients with community‐acquired infection in emergency department

open access: yesHong Kong Journal of Emergency Medicine, Volume 27, Issue 5, Page 277-285, September 2020., 2020
Background: Early and effective treatment of patients with sepsis requires early recognition in emergency department and understanding the severity of the disease. Many studies have been conducted for this purpose, and many of scoring systems have been developed that provide early recognition of these patients and show their severity.
Maruf Beğenen   +3 more
wiley   +1 more source

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis [PDF]

open access: yesJournal of Managed Care & Specialty Pharmacy, 2016
It is estimated that acute bacterial skin and skin structure infections (ABSSSI) account for nearly 10% of hospital admissions and 3.4-3.8 million emergency department visits per year in the United States. Analyses of hospital discharge records indicate 74% of ABSSSI admissions involve empiric treatment with methicillin-resistant Staphylococcus aureus (
Ivar S, Jensen   +7 more
openaire   +2 more sources

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: Delafloxacin is a broad-spectrum anionic fluoroquinolone with activity against Gram-positive and Gram-negative organisms, including methicillin-resistant Staphylococcus aureus.
Dee Shortridge   +3 more
doaj   +1 more source

456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial [PDF]

open access: yesOpen Forum Infectious Diseases, 2019
Abstract Background Prolonged admissions for acute bacterial skin and skin structure infections (ABSSSI) present an opportunity to improve efficiency and quality of care. A primary reason for admission for ABSSSI is to receive intravenous (IV) antibiotics, where multiple guidelines support shifting ...
McCarthy, Matthew W   +5 more
openaire   +1 more source

Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis

open access: yesJournal of Infection and Public Health, 2023
Background: The treatment of acute bacterial skin and skin structure infections (ABSSSI) usually involves intravenous (i.v.) antibiotics requiring hospitalisation and increasing hospital costs.
Christoph T. Baltin   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy